Comparative Pharmacology
Head-to-head clinical analysis: ADDERALL 15 versus METHAMPHETAMINE HYDROCHLORIDE.
Head-to-head clinical analysis: ADDERALL 15 versus METHAMPHETAMINE HYDROCHLORIDE.
ADDERALL 15 vs METHAMPHETAMINE HYDROCHLORIDE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Adderall 15 is a combination of amphetamine and dextroamphetamine, which increase synaptic concentrations of norepinephrine and dopamine by inhibiting their reuptake and promoting their release from presynaptic terminals.
Methamphetamine is a potent central nervous system stimulant that increases synaptic concentrations of dopamine, norepinephrine, and serotonin by reversing their transporters, inhibiting monoamine oxidase, and inhibiting vesicular monoamine transporter 2 (VMAT2).
10-20 mg orally once daily in the morning; may increase by 5-10 mg weekly; maximum 40 mg/day.
Oral: 5-10 mg once or twice daily, titrated up to a maximum of 60 mg/day in divided doses. Typical initial dose for ADHD: 5 mg once or twice daily, increase by 5 mg weekly; for obesity: 5 mg before meals, up to 30 mg/day.
None Documented
None Documented
Mean terminal half-life: d-amphetamine 10 h, l-amphetamine 13 h (range 9-14 h); for ADDERALL 15 (3:1 mix), effective half-life ~11 h; clinical context: dosing interval typically QD-BID.
Terminal elimination half-life: 10-12 hours. Clinical context: Longer half-life than amphetamine (6-8 h) due to higher lipophilicity and tissue binding. Variability (4–30 h) depends on urine pH, dose, and chronic use (tissue accumulation).
Primarily renal (90% as unchanged drug and metabolites; ~30% unchanged, 40% as 4-hydroxyamphetamine and conjugates, 20% as other metabolites); minimal biliary/fecal elimination (<3%).
Primarily renal excretion of unchanged drug (30-50%) and metabolites (p-hydroxymethamphetamine, amphetamine, p-hydroxyamphetamine). Up to 70% eliminated over 24 hours. Renal clearance depends on urinary pH; acidic urine (pH <5) increases elimination, alkaline urine reduces it. Biliary/fecal excretion is minimal (<5%).
Category C
Category D/X
CNS Stimulant
CNS Stimulant